SERA PROGNOSTICS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent
SERA PROGNOSTICS, INC. (SERA) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent of -1.09% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch · last filed 2026-03-18
- SERA PROGNOSTICS, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2025 was -1.09%.
- SERA PROGNOSTICS, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2024 was -2.13%.
- SERA PROGNOSTICS, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2023 was -1.93%.
- SERA PROGNOSTICS, INC. effective income tax rate reconciliation, tax credit, research, percent for fiscal 2022 was -1.28%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -1.09% 10-K · filed 2026-03-18 | |
| 2024-12-31 | -2.13% 10-K · filed 2026-03-18 | -2.54% 10-K · filed 2025-03-19 |
| 2023-12-31 | -1.93% 10-K · filed 2025-03-19 | |
| 2022-12-31 | -1.28% 10-K · filed 2024-03-20 | |
| 2021-12-31 | -1.26% 10-K · filed 2023-03-22 | |
| 2020-12-31 | -1.53% 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |